State of Tennessee, Department of Treasury’s Adaptimmune Therapeutics ADAP Stock Holding History

State of Tennessee, Department of Treasury’s Portfolio ADAP Stock Details ADAP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-73,376	Closed	-$9.54K	–	1730
2025 Q3	$9.54K	Hold	73,376	–	–	﹤0.01%	1727
2025 Q2	$17.6K	Hold	73,376	–	–	﹤0.01%	1719
2025 Q1	$14.5K	Buy	+73,376	New	+$38K	﹤0.01%	1717
2023 Q2	–	Sell	-13,100	Closed	-$14.3K	–	1708
2023 Q1	$14.3K	Hold	13,100	–	–	﹤0.01%	1649
2022 Q4	$19K	Buy	+13,100	New	+$21.2K	﹤0.01%	1619
2021 Q1	–	Sell	-47,240	Closed	-$255K	–	1615
2020 Q4	$255K	Buy	+47,240	New	+$257K	﹤0.01%	1434
2019 Q3	–	Sell	-6,085	Closed	-$24K	–	1584
2019 Q2	$24K	Hold	6,085	–	–	﹤0.01%	1552
2019 Q1	$26K	Hold	6,085	–	–	﹤0.01%	1586
2018 Q4	$35K	Buy	+6,085	New	+$44.9K	﹤0.01%	1554

Other funds holding ADAP

JAIC

Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return

Empirical Finance Havertown, Pennsylvania $2.13B AUM 29.56% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

State of Tennessee, Department of Treasury's ADAP Position: Q4 2025 in Review

State of Tennessee, Department of Treasury sold out of Adaptimmune Therapeutics (ADAP) in Q4 2025, closing a stake of 73,376 shares — an estimated $9.54K sold.

State of Tennessee, Department of Treasury first reported a position in ADAP in Q4 2018 and held it in 9 quarters. The position peaked at $255K in Q4 2020. 10 funds tracked by Wall St. Rank hold ADAP as of Q4 2025.

State of Tennessee, Department of Treasury reported no remaining Adaptimmune Therapeutics position as of Q4 2025 after selling out during the quarter.
State of Tennessee, Department of Treasury sold 73,376 Adaptimmune Therapeutics shares in Q4 2025, an estimated $9.54K.
State of Tennessee, Department of Treasury first reported a position in Adaptimmune Therapeutics in Q4 2018 and held it in 9 quarters.
State of Tennessee, Department of Treasury's Adaptimmune Therapeutics position peaked at $255K in Q4 2020.
10 funds tracked by Wall St. Rank held Adaptimmune Therapeutics as of Q4 2025.

Based on State of Tennessee, Department of Treasury's 13F filing for Q4 2025, filed 18 Feb 2026.